View of THE ECONOMIC BURDEN OF TREATING NASOPHARYNGEAL CARCINOMA PATIENTS (NPC) USING THE MALAYSIAN DIAGNOSIS-RELATED GROUPS (MY-DRG) TARIFF AND CLINICAL FACTORS ASSOCIATED WITH THE MY-DRG TARIFF BASED ON THE CASEMIX SYSTEM

Return to Article Details THE ECONOMIC BURDEN OF TREATING NASOPHARYNGEAL CARCINOMA PATIENTS (NPC) USING THE MALAYSIAN DIAGNOSIS-RELATED GROUPS (MY-DRG) TARIFF AND CLINICAL FACTORS ASSOCIATED WITH THE MY-DRG TARIFF BASED ON THE CASEMIX SYSTEM Download Download PDF